CapitalBio Technology
Beijing · Founded 2012
About CapitalBio Technology
CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Their company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Their products include an innovative and broad spectrum of microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding. As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is headquartered in Economic-Technological Development Area in Beijing. CapitalBio Technology is a leading life science company that develops and commercializes total health-care solutions. With more than 35,000 square meters of office space, CapitalBio Technology employs more than 500 employees; 86 percent of these employees have at least Bachelor-level degrees, 14 of which are doctors or post-doctorates.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $118.0M
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2021)
- Website: https://www.capitalbiotechnology.com
- Phone: 86-10-69002900
Industries & Categories
AgTech, Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/capitalbio-technology-11057 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.